301060SZSE

Lanwei Medical Co., Ltd.

兰卫医学

301060

Shenzhen Stock Exchange

Follow
38 announcements tracked· Last: May 22, 2026

Key Financials

Revenue¥287.2M
Net Profit¥36.9M
ROE2.33%
Debt Ratio28.37%
Monetary Funds¥846.1M
Receivables¥657.7M
Goodwill¥7.7M
Total Shares400.5M

Announcements

38 total

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal Opinion on the 2025 Annual Shareholders Meeting of Shanghai Lanwei Medical Testing Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement on the 2026 Annual Remuneration Plan for Company Directors and Senior Management

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Board Work Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Shareholder Return Plan for the Next Three Years (2026-2028)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Guojin Securities Co., Ltd. Review Opinion on Shanghai Lanwei Medical Testing Co., Ltd. 2025 Annual Fundraising Storage and Usage

Share PledgeShareholding Change DisclosureCapital Reduction

Legal Opinion from Shanghai Chengming Zezheng Law Firm on the Invalidated Restricted Stock Incentive Plan Granted but Unvested by Shanghai Lanwei Medical Testing Co., Ltd.

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

Announcement on the Reappointment of Accounting Firm

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Independent Director 2025 Work Report (Jiang Huiping)

Convertible BondsShareholding Change DisclosureCapital Reduction

Independent Director 2025 Work Report (Qiu Guohua)

Convertible BondsShareholding Change DisclosureCapital Reduction

Independent Director 2025 Work Report (Shi Daojin)

Convertible BondsShareholding Change DisclosureCapital Reduction

Announcement on Holding the 2025 Performance Briefing

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Environmental, Social, and Corporate Governance Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Internal Control Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Internal Control Evaluation Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Remuneration Management System for Directors and Senior Management

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Provision and Reversal of Impairment Reserves for Q1 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Provision and Reversal of Impairment Reserves for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Expected Daily Related Transactions for 2026 and Confirmation of Related Transactions for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Using Idle Self-Owned Funds to Purchase Financial Products

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Company's and Subsidiaries' Proposed Comprehensive Credit Line Application to Banks for 2026 and Expected Guarantee Amounts for 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Dongguan Lanwei's Proposal to Provide Financial Assistance to Subsidiary Lanbowei

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice of the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Resolution Announcement of the 9th Meeting of the 4th Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the 2025 Annual Profit Distribution Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Q1 2026 Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Report on the Storage, Management, and Usage of Raised Funds for 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Verification Report on Annual Storage, Management, and Usage of Raised Funds

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

2025 Annual Special Audit Report on Revenue Deduction

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Evaluation Report on the Performance of the Accounting Firm and the Audit Committee's Supervision Responsibilities

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

2025 Annual Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Report on the Board's Self-Examination of Independent Directors' Independence

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Report Summary

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Invalidating Certain Granted but Unvested Restricted Stocks from the 2022 Restricted Stock Incentive Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on Requesting Shareholder Meeting Authorization for the Board to Issue Stocks to Specific Objects via Simplified Procedures

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notes & Comments

Sign in to leave a comment or private note.

Loading…